NT_1170x120_1-11-18

levocetirizine

Dr. Reddy’s aims to widen access to affordable Rxs

Dr. Reddy’s aims to widen access to affordable Rxs

HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. is building a pathway to long-term future growth on a strong foundation of capabilities. The innovation-focused pharmaceuticals manufacturer is well positioned to adapt to the swiftly changing global market and emerging opportunities in health care. According to Alok Sonig, chief executive officer for developed markets, Dr. Reddy’s is

Sanofi cleared to market OTC Xyzal allergy medicine

Sanofi cleared to market OTC Xyzal allergy medicine

BRIDGEWATER, N.J. — Sanofi is adding to its roster of prescription-to-OTC allergy medications with Xyzal Allergy 24HR. The Food and Drug Administration has approved Xyzal Allergy 24HR (levocetirizine dihydrochloride) as an over-the-counter treatment to alleviate symptoms of seasonal and year-round allergies, Sanofi said Wednesday. The product offers proven 24-hour relief from runny nose, sneezing, itchy